Relisys Medical Devices Profile
Key Indicators
- Authorised Capital ₹ 51.50 Cr
- Paid Up Capital ₹ 38.07 Cr
- Company Age 27 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 58.49 Cr
- Satisfied Charges ₹ 96.45 Cr
- Revenue Growth 46.28%
- Profit Growth 35.04%
- Ebitda 42.81%
- Net Worth 21.32%
- Total Assets 15.66%
About Relisys Medical Devices
Relisys Medical Devices Limited (RMDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 13 October 1997 and has a history of 27 years and three months. Its registered office is in Ibrahimpatnam, Andhra Pradesh, India.
The Corporate was formerly known as Care Polymed Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 51.50 Cr and a paid-up capital of Rs 38.07 Cr.
The company currently has active open charges totaling ₹58.49 Cr. The company has closed loans amounting to ₹96.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Relisys Medical Devices Limited India are Muthyam Pundra as CFO and Sujatha Devineni as Company Secretary. Navin Rajpal, Kumar Jain, Shaun Khubchandani, and Three other members serve as directors at the Company.
Company Details
-
Location
Ibrahimpatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85101TG1997PLC028153
-
Company No.
028153
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
13 Oct 1997
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Relisys Medical Devices Limited offer?
Relisys Medical Devices Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Catheter, Endoscopy & Laparoscopy instruments, Cardiac Surgery Equipment, Forceps & Graspers.
Who are the key members and board of directors at Relisys Medical Devices?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Nallamalla
|
Managing Director | 01-Aug-2003 | Current |
| Muthyam Pundra | CFO | 13-Jan-2024 | Current |
| Sujatha Devineni | Company Secretary | 01-Apr-2021 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sridevi Chennapragada
|
Director | 09-Dec-2017 | Current |
|
Navin Rajpal
|
Whole-Time Director | 17-Aug-2021 | Current |
|
Kumar Jain
|
Nominee Director | 17-Aug-2021 | Current |
|
Shaun Khubchandani
|
Nominee Director | 28-Mar-2022 | Current |
|
Subramanian Shivaraman
|
Director | 22-May-2017 | Current |
Financial Performance of Relisys Medical Devices.
Relisys Medical Devices Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.28% increase. The company also saw a substantial improvement in profitability, with a 35.04% increase in profit. The company's net worth Soared by an impressive increase of 21.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relisys Medical Devices?
In 2023, Relisys Medical Devices had a promoter holding of 34.56% and a public holding of 65.44%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Meditix Solutions Private LimitedSubramanian Shivaraman is a mutual person
-
Incumed LlpKrishna Nallamalla is a mutual person
-
Fibroheal Woundcare Private LimitedSubramanian Shivaraman is a mutual person
-
Aqmen Medtech Private LimitedSubramanian Shivaraman is a mutual person
-
Baazar Retail Private LimitedKumar Jain is a mutual person
-
Multimedics LlpSubramanian Shivaraman and Krishna Nallamalla are mutual person
Charges (Loans)
₹58.49 Cr
₹96.45 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 50.49 Cr
- Biotechnology Industry Research Assistance Council : 8.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2023 | Hdfc Bank Limited | ₹2.73 M | Open |
| 21 Mar 2022 | Hdfc Bank Limited | ₹1.21 M | Open |
| 07 Jan 2022 | Hdfc Bank Limited | ₹50.00 Cr | Open |
| 06 Jan 2022 | Hdfc Bank Limited | ₹1.00 M | Open |
| 22 Jul 2009 | Biotechnology Industry Research Assistance Council | ₹8.00 Cr | Open |
How Many Employees Work at Relisys Medical Devices?
Relisys Medical Devices has a workforce of 226 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relisys Medical Devices, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relisys Medical Devices's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
